Author:
Tsopka Ioanna-Chrysoula,Hadjipavlou-Litina Dimitra
Reference44 articles.
1. Jabir NR, Rehman MT, Alsolami K, Shakil S, Zughaibi TA, Alserihi RF et al (2021) Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment. Ann Med 53(1):2332–2344
2. Alzheimer’s association (USA) (2022) Alzheimer’s disease facts and figures 2022
3. Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules (Basel, Switzerland). NLM (Medline) 25:5789
4. Fedele E, Ricciarelli R (2021) Memory enhancers for Alzheimer’s dementia: focus on cgmp. Pharmaceuticals. MDPI AG 14:1–14
5. Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA et al (2009) Lipopolysaccharide alters the blood-brain barrier transport of amyloid β protein: a mechanism for inflammation in the progression of Alzheimer’s disease. Brain Behav Immun 23(4):507–517